Home Applications 219239 Application 219239
Type ANDA
Sponsor GLAND Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 EPINEPHRINE EPINEPHRINE SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 10MG/10ML (1MG/ML) No No 002 EPINEPHRINE EPINEPHRINE SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 30MG/30ML (1MG/ML) No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A219239-001 EPINEPHRINE EPINEPHRINE 10MG/10ML (1MG/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS AP 2025-02-06 A219239-002 EPINEPHRINE EPINEPHRINE 30MG/30ML (1MG/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS AP 2025-10-02
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A219239-001 EPINEPHRINE 10MG/10ML (1MG/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS AP 2025-02-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A219239-002 EPINEPHRINE 30MG/30ML (1MG/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS AP 2025-10-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219239-001 EPINEPHRINE 10MG/10ML (1MG/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS AP 2025-02-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219239-002 EPINEPHRINE 30MG/30ML (1MG/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS AP 2025-10-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A219239-001 EPINEPHRINE 10MG/10ML (1MG/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS AP 2025-02-06 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A219239-001 EPINEPHRINE 10MG/10ML (1MG/ML) SOLUTION / INTRAMUSCULAR, INTRAOCULAR, SUBCUTANEOUS AP 2025-02-06 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A219239-001 EPINEPHRINE 10MG/10ML (1MG/ML) SOLUTION / INTRAMUSCULAR, INTRAOCULAR, SUBCUTANEOUS AP 2025-02-06 b8a1b40f171c…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219239-001 EPINEPHRINE 10MG/10ML (1MG/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS AP 2025-02-06 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219239-002 EPINEPHRINE 30MG/30ML (1MG/ML) SOLUTION / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS AP 2025-10-02 a50c72e98297…
Observed Orange Book normalized TE history# Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219239-001 CGT 2025-09-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A219239-001 CGT 2025-09-03 6a471c1ec25d…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Documents# Document, Submission type, Date table Document Submission type Date 81472 ORIG 2025-03-06